Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Data Commons to Support Pediatric Cancer ResearchSamuel L Volchenboum, Suzanne M Cox, Allison Heath, et al.
Pediatric Blood & Cancer|September 25, 2014
Second malignancies in patients with neuroblastoma: the effects of risk-based therapyMark A Applebaum, Tara O Henderson, Sang Mee Lee, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
JCO Clinical Cancer Informatics|December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk GroupAnoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Hematology/Oncology Clinics of North America|June 10, 2026
Big Data in Pediatric Oncology: Hope, Hype, RealityKirk D Wyatt, Samuel L Volchenboum
JCO Clinical Cancer Informatics|May 30, 2024
Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services ModuleBrian Furner, Alex Cheng, Ami V Desai, et al.
JCO Oncology Practice|February 22, 2024
Targeted Enrollment in Pediatric Oncology Trials: A Vision for Just-in-Time MatchingKirk D Wyatt, Samuel L Volchenboum
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaborationChaim Kirby, Peter F Ambros, David Billiter, et al.
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastomaRiyue Bao, Stefani Spranger, Kyle Hernandez, et al.
Pageof 22